Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 12; p. 652130
Main Authors Almeida, Roberto F, Ferreira, Tiago P, David, Camila V C, Abreu E Silva, Paulo C, Dos Santos, Sulamita A, Rodrigues, Ana L S, Elisabetsky, Elaine
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 13.04.2021
Subjects
guanine-based purines
guanosine
major depressive disorder
Pharmacology
psychopharmacology
purinergic signaling system
purines (source: MeSH)
purinergic signaling system
psychopharmacology
guanosine
major depressive disorder
purines (source: MeSH)
guanine-based purines
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
orcid.org/0000-0002-0733-5917
orcid.org/0000-0001-6285-8780
Elaine Elisabetsky
orcid.org/0000-0002-1216-928X
Tiago Pedrosa Ferreira
ORCID
Camila Vieira Chagas David
Paulo Corrêa de Abreu e Silva
orcid.org/0000-0003-2857-9766
Edited by: Henning Ulrich, University of São Paulo, Brazil
orcid.org/0000-0003-3189-9752
Reviewed by: Rodrigo A Cunha, University of Coimbra, Portugal
Sulamita Aparecida Ambrosia dos Santos
orcid.org/0000-0002-9922-2863
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
Ana Lúcia S. Rodrigues
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2021.652130